News Release

New asthma tool determines best treatment for severe asthma patients

Allergy & Asthma Network, American College of Allergy, Asthma & Immunology (ACAAI) and CHEST Foundation have partnered to develop a shared decision making tool for adults with severe asthma

Business Announcement

American College of Chest Physicians

Shared Decision Making Tool

image: To help enable stronger communication and understanding between the clinician and patient, the CHEST Foundation, the charitable foundation of the American College of Chest Physicians, Allergy & Asthma Network and American College of Allergy, Asthma & Immunology (ACAAI) have partnered to launch a new digital, interactive Shared Decision Making Tool. view more 

Credit: CHEST Foundation, Allergy & Asthma Network and American College of Allergy, Asthma & Immunology.

One in 12 adults and one in 11 children in the United States are living with asthma, according to the Centers for Disease Control and Prevention (CDC). The communication between patients and clinicians is an important factor in proper management of a patient's symptoms and treatment.

To help enable stronger communication and understanding between the clinician and patient, the CHEST Foundation, the charitable foundation of the American College of Chest Physicians, Allergy & Asthma Network and American College of Allergy, Asthma & Immunology (ACAAI) have partnered to launch a new digital, interactive Shared Decision Making Tool.

Asthma is a complex, ever changing condition requiring active attention. It affects more than 22 million Americans, and some patients may believe their asthma is well-controlled when it's not--this misconception can be dangerous. The tool sheds light on the importance of self-management, shared decision making between patient and provider and knowledge of the difference between controlled and uncontrolled asthma. It can also assist patients in recognizing when their asthma is severe.

"The CHEST Foundation, Allergy & Asthma Network and ACAAI all believe in the importance of patient and provider collaboration and aim to provide resources that help develop that relationship," said Lisa Moores, MD, FCCP, CHEST Foundation President.

The Shared Decision Making Tool, available online and in print, encourages patients and clinicians to work together to improve self-management skills, choose the best treatment plan and increase adherence. This patient-centered approach aims to improve patient satisfaction and overall outcomes.

In addition to the Shared Decision- Making Tool, the Asthma Severity Assessment Tool was created to improve patient awareness, monitoring and management of asthma symptoms. Based on an individual's responses, this quick assessment helps determine if a patient may need to visit an asthma specialist - a pulmonologist or an allergist.

"We hope these tools will arm patients with the knowledge needed to talk effectively with doctors about their asthma and empower them to achieve optimal health outcomes," said Tonya Winders, Allergy & Asthma Network President and CEO.

"The tool is a step forward in helping direct the conversation between allergists and their patients with asthma," says allergist Bradley Chipps, MD, ACAAI president. "Fully informed conversations regarding asthma treatment mean greater asthma control and ultimately increased relief for those suffering with asthma."

###

This CHEST Foundation and Allergy & Asthma Network asthma campaign and other collateral pieces are generously supported by AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Sanofi/Regeneron.

About Allergy & Asthma Network

Allergy & Asthma Network is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. Allergy & Asthma Network specializes in sharing family-friendly, medically accurate information through its award-winning Allergy & Asthma Today magazine, e-newsletter, AllergyAsthmaNetwork.org and numerous community outreach programs.

Follow Allergy & Asthma Network on Facebook, Twitter and Instagram at @AllergyAsthmaHQ.

About American College of Allergy, Asthma & Immunology

The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Illinois. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

About the CHEST Foundation

The CHEST Foundation, the charitable foundation of the American College of Chest Physicians, champions lung health by supporting clinical research, community service,and patient education. Through CHEST Foundation- supported programs, CHEST's 19,000+ members engage in advancing the lung health of millions of patients in local communities around the world. More than 95 cents of every dollar raised goes toward advancing the foundation's mission-based programming. Since its inception, the foundation has provided more than $10 million in funding for clinical research and community service, with a reach that spans more than 60 countries. For more information about the CHEST Foundation, visit chestfoundation.org.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.